CalciMedica, Inc. Common Stock (NYSE: CALC) — Healthcare · Share Price, Chart & Market Data
About: CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.58 (+0.78%)
CALCCalciMedica, Inc. Common Stock
Loading watchlist status…
Trade CALC now
CalciMedica, Inc. Common Stock share price
CALC price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:24 pm GMT+0
CALC price performance
-3.325%
5D
2.724%
1M
-91.328%
YTD
-61.291%
1Y
CALC price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:24 pm GMT+0
CALC details
CALC Market Signals